Amniotic fluid embolism
From WikiAnesthesia
Revision as of 12:43, 20 October 2022 by Olivia Sutton (talk | contribs)
Amniotic fluid embolism
Anesthetic relevance | |
---|---|
Anesthetic management |
{{{anesthetic_management}}} |
Specialty | |
Signs and symptoms | |
Diagnosis | |
Treatment | |
Article quality | |
Editor rating | |
User likes | 0 |
An amniotic fluid embolism (AFE) is a rare but serious condition with high morbidity and mortality. It is characterized by cardiopulmonary collapse and disseminated intravascular coagulation (DIC). It is the second-leading cause of peripartum maternal death in the US and number one cause of peripartum cardiac arrest. [1]
Anesthetic implications
Preoperative optimization
Intraoperative management
Postoperative management
Risk Factors
Risk factors for the development of AFE are advanced maternal age, multiparity, male fetuses, and trauma.
Pathophysiology
AFE is poorly understood.
Signs and symptoms
Diagnosis
Treatment
Medication
Surgery
Prognosis
Epidemiology
References
- ↑ Haftel, Anthony; Chowdhury, Yuvraj S. (2022), "Amniotic Fluid Embolism", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 32644533, retrieved 2022-10-20